To view more alumni events, click here.
The Malone Center for Engineering in Healthcare hosts the inaugural Johns Hopkins Research Symposium on Engineering in Healthcare.
Cutting-edge engineering innovations advancing the delivery of high-value healthcare will be presented in four thematic panels:
A poster presentation will be available for review throughout the symposium. A discussion session with the poster presenters is scheduled immediately after the last symposium panel. See preliminary program and more details here.RSVP by Friday, October 31, 2016
Robert M. Nerem (Georgia Institute of Technology) presents “Regenerative Medicine: The Hype, the Hope, and the Future” as part of a special seminar hosted by the Department of Biomedical Engineering, the Institute for NanoBioTechnology, and the Translational Tissue Engineering Center.
Abstract: Although the underlying concepts of tissue engineering and regenerative medicine go back more than 75 years, the term tissue engineering actually was only “coined” in the 1980s. This was followed by the 1990s being the “go-go” years with stem cells emerging as a technology, an industry developing, and the term regenerative medicine beginning to be used. There also was a lot of hype, and following the turn of the century the field entered what might be called the “sobering” years, with private sector activity falling significantly even though the science continued to advance. The last decade, however, has all the marks of being “back to the future.” Advances in cell-based therapies have been fueled by advances in stem cell science and technology and the discovery of what is required to reprogram somatic cells into stem cells, known as induced pluripotent stem (iPS) cells. For cellular therapies, a key question is what is the mechanism of action? For a specific therapy, is the mechanism one of cell replacement or is it a paracrine effect? If the latter, is it possible that one could introduce the appropriate biological signals without the use of cells? In this case the discussion shifts from “my cell is better than your cell” to “my biological signals are better than yours.” Whatever the case, one of the “holy grails” is the neurodegenerative diseases/disorders and the repair/regeneration of the central nervous system. Instead of the mixture of hype and hope in the past, and with an aging population providing the threat of a “tsunami” of neural disorders, regenerative medicine offers the real possibility of cures to these diseases/disorders in the future.
Join the Johns Hopkins Center for Bioengineering Innovation and Design for a review of many exciting healthcare design projects at the CBID Annual Fall Showcase & Shark Tank.
An alumni start-up panel will be featured this year and it’s not to be missed. The event will also include a Shark Tank competition with a panel of tough judges and real cash prizes. Light refreshments will be provided.